Last Call NVLX...In the very near term, the comprehensive scientific news of the preclinical study will become evident. Nuvilex and their team of highly qualified medical scientists are shifting the medical paradigm for targeted prodrug delivery in a measured and calculated manner. Patients will soon reap benefits. Stockholders will also. GLTA
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.